Near-infrared fluorescence imaging in the 1500 nm-1700 nm sub-window (NIR-IIb) has shown deeper penetration depth, higher resolution and zero auto-fluorescence for biomedical imaging. Till now, very few small molecular NIR-IIb fluorophores have been reported due to extremely rare organic NIR-IIb skeleton and notorious aggregation-caused quenching (ACQ) effect in aqueous solution. In this study, highly twisted NIR-II small molecular fluorophore such as HL3 (45.5 o at S 0 state) with the emission wavelength extending into the NIR-IIb region was designed and synthesized by aggregation-induced emission (AIE) strategy. HL3 dots showed a remarkable increase in the fluorescence intensity with the QYs of 11.7% in the NIR-II window (> 1000 nm) and 0.05% in the NIR-IIb region (> 1550 nm) in water. High-resolution in vivo imaging of the whole body, cerebral vasculature, and lymphatic drainage beyond 1550 nm were achieved using NIR-II AIE HL3 dots for the first time. These attractive results may promote the development of small-molecule NIR-IIb fluorophores with maximum emission wavelength beyond 1500 nm with deeper penetration depth and higher resolution.
Introduction
Optical fluorescence imaging is a promising modality for realtime monitoring of disease progression, drug delivery and image-guided surgery with high spatial and temporal resolution. 1 However, the traditional fluorescence imaging techniques were mostly focused on the visible and near-infrared region below 900 nm, where imaging resolution and penetration depths were largely limited due to the photo-scattering, auto-fluorescence and absorption of biological tissues. Hence, developing novel fluorophores with longer emission wavelengths to improve imaging resolution for in vivo deeper imaging is crucial and still a great challenge. 2 During the past few years, molecular imaging in the second near-infrared region (NIR-II, 1000-1700 nm) was emerged as a powerful tool for the delineation and treatment of cancers. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] The first organic small-molecule dye CH1055 with 90% renal excretion for NIR-II bio-imaging was reported in 2015, 5 and opened up a new era for small molecular imaging. Deeper imaging depths (up to 3 cm), excellent temporal and spatial resolutions (50 FPS and 1 μm), and a higher tumor-to-normal tissue (T/NT) ratio (up to 15) were achieved in the NIR-II region. 5, 12 Especially, NIR-IIb sub-window (1500-1700 nm) showed tremendous advantages of near-zero auto-fluorescence, negligible scattering, and unparalleled tissue-imaging depths, and turned out to be a hot spot on in vivo fluorescence bioimaging. 13 Very few inorganic NIR-IIb fluorophores such as single-walled carbon nanotubes (SWNTs), rare earth doped nanoparticles, and quantum dots have been investigated for biosensing and bioimaging beyond 1500 nm. 7g, 8f, 13-17 It is worth noting that organic FD-1080 J-aggregates were firstly accomplished with high resolution imaging of cerebral and hindlimb vasculature with the fluorescence emission tailing into 1500 nm in quantum yield (QY) of 0.0545%. 17 The signal-tobackground (SBR) was 3.3-fold higher than that of NIR-IIa (1300-1400 nm). However, small-molecule NIR-IIb fluorophores (beyond 1500 nm) are still in its fancy. Shifting small-molecule NIR-II fluorophore emissions, specifically into the NIR-IIb sub-window, is great challenging but crucial for expansion its in vivo biomedical applications. Thus, it is imperative to pursuit for new sorts of small molecular NIR-IIb dyes for enhanced optical imaging.
Here, we have rationally designed and synthesized the newly fluorescent probes HL1-HL3 based on our previous reported NIR-II fluorophores H1 7d and Q4 6a . Hexyloxy chain substitution at position R 1 and R 2 of thiophene not only served as a strong donor, but also significantly increased the dihedral angle up to 45.5 o between BBTD and thiophene for the S 0 geometries (Fig.  1 ). Among them, HL3 showed remarkable brightness, excellent AIE features with the fluorescence emission stretching to 1550 nm in quantum yield of 0.05%. Furthermore, in vivo imaging beyond 1550 nm of the blood vessels, cerebral vasculature, and lymph nodes were evaluated for the first time. Fig. 1 The chemical structure and optimized ground state geometries (S 0 ) of HL1-HL3 by using the Gaussian 09 software.
Results and discussion
A vast majority of small-molecule NIR-II contrast agents were constructed by the donor-acceptor-donor (D-A-D) backbones, in which benzobisthiadiazol (BBTD) used as the electron acceptor unit. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Nevertheless, the fluorescence quantum yields of organic NIR-II chromophores in aqueous solution were relative low. The rigid planar aromatic structures with tremendous intermolecular π-π stacking interactions, and the dominated non-radiative decay may attribute to the aggregation-caused quenching (ACQ) effect in low-bandgap materials. 18 A feasible solution is to fully use the brightness of dihedral twisted NIR-II backbones with stout emission extending into the NIR-IIb region by the aggregation-induced emission (AIE) strategy. [18] [19] [20] [21] [22] Thus, three novel organic small-molecule NIR-II fluorophores HL1-HL3 were designed ( Fig. 1 ). 3, 4bis(hexyloxy)thiophene was served as the first donor (D1), and triphenylamine was utilized as the second donor (D2) and a building block of AIEgens. In addition, the influence of electron-withdrawing group nitrobenzene and electron donating group aminobenzene on the whole backbone were also investigated. Density function theory (DFT) was first employed to calculate the electronic properties of HL1-HL3 by Gaussian 09 software using method of the B3LYP/6-31G(d). For the optimized ground state (S 0 ) geometries, the twisted angles of HL1-HL3, H1 and Q4 were calculated. All dihedral angels of HL1-HL3 between BBTD and donor 3, 4-bis(hexyloxy)thiophene were ~ 45 o (Fig. 1) , exhibiting more distortion than that of Q4 (~ 1.9 o ) and H1 (~ 0.3 o ) (Fig. S1 ). The E gap of HL1 (1.78 eV) indicated short wavelength infrared characteristics (Table S1 ). Moreover, the E gap of HL2 and HL3 was 1.45 eV and 1.48 eV respectively ( Fig. S2 ), lower than that of CH1055 (1.5 eV) with a typical NIR-II optical E gap , resulting in a hypsochromic shift compared to H1 (1.21 eV) and Q4 (1.12 eV) (Table S1 ). The small-molecule fluorophores HL1-HL3 were synthesized mainly through Still coupling, Zn reduction, N-thionylaniline-induced ring closure and Suzuki coupling in 45-50% yield over 4 steps from compound 1 (Fig. 2 and ESI) . The structures were confirmed by 1 H NMR, 13 C NMR, MALDI-TOF-MS or ESI-MS ( Fig. S12-S26 ). The spectroscopic properties of HL1-HL3 in THF were shown in Fig. 3B and 3C, and it was found that their maximum emission wavelengths were ~ 922 nm, 1062 nm and 1050 nm respectively, which were in consistence with the results of E gap calculated by the Gaussian 09 software using 6-31G(d, p). HL3 exhibited a remarkable increase in fluorescent intensity with a strong tail into 1500 nm region (Fig. 3C ). The molar extinction coefficients (ε) of HL1-HL3 in THF were measured as 8.3 ×10 3 L.mol -1 .cm -1 , 4.1 ×10 3 L.mol -1 cm -1 and 7 ×10 3 L.mol -1 .cm -1 respectively. The QYs of HL1-HL3 in THF were measured as 0.2%, 0.34% and 2% with IR-26 (QY: 0.5%) as a reference, respectively (Fig. S3 ). The AIE properties of HL1-HL3 were studied in the THF/water mixture solvents with increasing water volume fraction (fw). As shown in Fig. 3A, HL3 exhibited extremely strong fluorescence emission in THF/water with 90% fw. To further confirm the AIE properties of HL1-HL3, the fluorescence emission spectra in with different fws were subsequently investigated under 808 nm excitation (Fig. 3D, S4 and 3E ). The fluorescence (FL) intensity of HL1-HL3 was gradually decreased with the increase of fw from 0 to 40-50%, and increased sharply for HL3 from fw 50% to 90%, indicating a typical AIE characteristic. Meanwhile, no AIE characteristics were observed for H1 and Q4 in the similar conditions. High monodispersity and homogeneity HL2 and HL3 dots were prepared in amphiphilic DPPE-5KPEG (Fig. S5, S6 and 4A ). HL3 dots were characterized for bioimaging applications by transmission electron microscope (TEM), dynamic light scattering (DLS) and the zeta potential with an average size ~ 90 nm, a dynamic size of ~ 120 nm (Fig. 4B ) and ~ -9.2 eV, respectively (Fig. S7) The encapsulation efficiency of HL3 dots was investigated as ~ 82% (Fig. S8) . The maximum absorption wavelength was 750 nm (Fig. 4C) . The maximum emission wavelength was centered in 1050 nm and tailed Please do not adjust margins Please do not adjust margins to 1600 nm (Fig. 4D) . The quantum yields were calculated as ~11.7% in the NIR-II region (1000-1700 nm) and ~ 0.05% in the NIR-IIb region (beyond 1550 nm). The molar extinction coefficient (ε) of HL3 dots in water was measured as 9.3 ×10 3 L.mol -1 .cm -1 . The reasonable quantum yields and NIR-IIb fluorescence emission of HL3 dots encouraged us to explore their NIR-IIb imaging capabilities in vitro. HL3 dots exhibited excellent fluorescence intensity beyond 1550 nm under 808 nm laser irradiation (1550 nm LP, Fig. 4D ) As shown in Fig. 4E , the fluorescence intensity of HL3 dots showed no obvious changes in different medium (FBS, PBS and water) under continuous 808 nm laser irradiation for 1 h (90 mW cm -2 ). L929 mouse fibroblast cells were applied to evaluate the potential cytotoxicity of HL3 dots by a standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. High cell viability was observed even at high concentration (100 μg/mL, Fig. 4F ). The pharmacokinetics of HL3 dots were also investigated through the measurement of the blood circulation half-life. The blood half-life of HL3 dots was 114 min (Fig.  S9 ). All these results have demonstrated that HL3 dots have superior stability and excellent biocompatibility, and are more applicable for NIR-IIb bioimaging (beyond 1550 nm) in vivo. To explore the feasibility of HL3 dots as a novel AIE NIR-IIb probe for reliable imaging of the whole body and cerebral vasculature system in KM mice and C57BL/6 mice (n = 3 per group), HL3 dots (200 μL, 1 mg/mL) were then injected into KM mice by the tail vein, NIR-II and NIR-IIb images of blood vessels were recorded by InGaAs camera using different LP filters (1000 nm, 1250 nm, 1550 nm) with different exposure times under 808 nm laser irradiation (90 mW cm -2 ). After 5 min post-injection, whole blood vessels were clearly visualized, and the hind limb vasculature was chosen for analysis via the Gaussian-fitted full width at half maximum (FWHM) (Fig. 5) . It was found that the imaging of HL3 dots in the NIR-II window (> 1250 nm, 1250 nm LP) with 50 ms exposure time exhibited higher superior resolution (Fig. 5B ). An extended exposure time (500 ms) was needed for higher resolution NIR-IIb imaging beyond 1550 nm (> 1550 nm, 1550 nm LP) (Fig. 5C ). The FWHM of the hind limb vasculature were 777 µm (1000 nm LP), 768 µm (1250 nm LP) and 719 µm (1550 nm LP), respectively. The signal-to-background ratio (SBR) of NIR-IIb imaging (SBR = 2.5, 1550 nm LP) was much higher than that of NIR-II imaging (SBR = 1.4, 1000 nm LP and SBR = 1.8, 1250 nm LP) (Fig. 5) . The cerebral vasculature system was also imaged by the NIR-IIb probe HL3 dots. The superior resolution of tiny vessels were obtained (Fig. 6) . The corresponding SBR of NIR-II 1000 nm, NIR-II 1250 nm and NIR-IIb 1550 nm imaging was 1.4, 1.8 and 3.4, respectively (Fig. 6D-6E ). The SBR of NIR-IIb imaging (1550 nm LP) was 2.4-fold higher than that of NIR-II imaging (1000 nm LP). The FWHM of the vessels at the same position (red dashed line) under different LP filters were calculated as 701 µm (1000 nm LP), 687 µm (1250 nm LP), 562 µm (1550 nm LP), respectively. The NIR-II fluorescence images using 1000 nm, 1250 nm and 1550 nm LP were also evaluated at the same exposure time (200 ms) at the concentration of 0.8 mg/mL. It was found that HL3 saturated detector using 1000 nm and 1250 nm long-pass filter under imaging conditions suitable for HL3 using 1550 nm long-pass filter (Fig. S10 ). All these results indicated that HL3 dots have great potential for in vivo NIR-IIb imaging (beyond 1500 nm) at the extended exposure time. The lymph node drainage plays a vital role in the tumor metastasis. We next demonstrated the application of HL3 dots for lymph nodes NIR-IIb imaging (beyond 1550 nm). HL3 dots (15 µL, 1 mg/mL) were injected intra-dermally at the left forefoot pad of KM mice (n = 3 per group) (Fig. 7) . The process of lymphatic drainage was monitored under 808 nm laser irradiation (90 mW cm -2 ) using 1550 nm LP. Lymphatic vessels were notably identified in 1 min after injection. The popliteal lymph node was gradually lighted up, and both popliteal lymph node and subiliac lymph node were clearly visualized in 2 h. The diameter of the lymphatic vessel between popliteal lymph node and subiliac lymph node was 533 µm via FWHM, and the SBR was reached to 4 (Fig. 7F) . The SBR of popliteal lymph node and subiliac lymph node were 2.5 and 3.2 (1000 nm LP), 2.9 and 3.4 (1250 nm LP), 5.1 and 4.8 (1550 nm LP), respectively (Fig.  S11) . These results revealed that NIR-IIb imaging beyond 1550 nm can achieve the imaging of lymph node drainage with higher SBR. figure Fig. 7D , cross-section intensity (black line), the lymphatic vessel (white-dashed lines).
Experimental Section
All animal experiments were performed according to the Chinese Regulations for the Administration of Affairs Concerning Experimental Animals and approved by the Institutional Animal Care and Use Committee (IACUC) of Wuhan University. And all experimental details are provided in the Supporting Information.
Conclusions
In summary, we have successfully synthesized a series of molecule fluorophores HL1-HL3 by introducing different donors and distortion groups. Among them, HL3 showed extremely stronger AIE characteristics and highly twisted donor-acceptor distortion. HL3 dots exhibited excellent water solubility, photo-stability and biocompatibility with a remarkable increase in NIR-II fluorescence intensity in the QYs of 11.7% and 0.05% in the NIR-II (> 1000 nm) and NIR-IIb region (> 1550 nm), respectively in water. Superior quality NIR-IIb imaging beyond 1550 nm of the whole body and cerebral vasculature, lymphatic drainage system were demonstrated in the first time with higher SBR. It is hoped that this novel NIR-II fluorophore HL3 integrated by AIE and D-A distortion strategy may become a practicable strategy to develop small-molecule NIR-IIb fluorophores with maximum emission wavelength beyond 1500 nm with deeper penetration depth and higher resolution.
Conflicts of interest
There are no conflicts to declare.
